Claris Biotherapeutics Funding & Investors
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
clarisbio.comTotal Amount Raised: $101,499,992
Claris Biotherapeutics Funding Rounds
Series A
$57,000,000
Series A Investors
Henderson Global InvestorsNovo HoldingsMass General Brigham VenturesRa Capital ManagementSeries Unknown
$44,499,994
Funding info provided by Diffbot.